Strategic Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$699K Hold
5,018
0.05% 186
2025
Q4
$616K Sell
5,018
-396
-7% -$48.1K 0.05% 143
2025
Q3
$601K Sell
5,414
-611
-10% -$69.4K 0.05% 147
2025
Q2
$668K Buy
6,025
+3,141
+109% +$334K 0.06% 129
2025
Q1
$323K Sell
2,884
-7,559
-72% -$780K 0.03% 201
2024
Q4
$965K Sell
10,443
-47,213
-82% -$4.25M 0.1% 117
2024
Q3
$4.83M Buy
57,656
+1,880
+3% +$143K 0.53% 40
2024
Q2
$3.83M Sell
55,776
-388
-0.7% -$25.9K 0.47% 40
2024
Q1
$4.11M Buy
56,164
+1,714
+3% +$132K 0.53% 39
2023
Q4
$4.41M Sell
54,450
-1,865
-3% -$145K 0.64% 36
2023
Q3
$4.22M Buy
56,315
+3,355
+6% +$258K 0.7% 27
2023
Q2
$4.08M Buy
52,960
+22,773
+75% +$1.82M 0.57% 26
2023
Q1
$2.5M Buy
30,187
+4,604
+18% +$381K 0.45% 36
2022
Q4
$2.2M Sell
25,583
-1,100
-4% -$87.1K 0.46% 37
2022
Q3
$1.65M Buy
26,683
+1,692
+7% +$107K 0.37% 50
2022
Q2
$1.54M Buy
24,991
+238
+1% +$14.7K 0.31% 55
2022
Q1
$1.47M Buy
24,753
+9,160
+59% +$586K 0.28% 61
2021
Q4
$1.13M Buy
+15,593
New +$1.07M 0.22% 87
2020
Q4
Sell
-4,766
Closed -$301K 196
2020
Q3
$301K Buy
4,766
+1,150
+32% +$79.7K 0.1% 140
2020
Q2
$278K Sell
3,616
-2,834
-44% -$217K 0.1% 140
2020
Q1
$482K Buy
6,450
+1,422
+28% +$98.3K 0.22% 81
2019
Q4
$327K Buy
5,028
+224
+5% +$14.6K 0.14% 123
2019
Q3
$304K Buy
+4,804
New +$314K 0.15% 111

Other funds holding GILD

Strategic Investment Advisors's GILD Position: Q1 2026 in Review

Strategic Investment Advisors held its Gilead Sciences (GILD) position steady in Q1 2026 at 5,018 shares worth $699K. The position accounts for 0.05% of the portfolio, ranked #186.

Strategic Investment Advisors first reported a position in GILD in Q3 2019 and has held it in 23 quarters since. The position peaked at $4.83M in Q3 2024. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Strategic Investment Advisors held 5,018 shares of Gilead Sciences worth $699K as of Q1 2026.
  • Strategic Investment Advisors left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.05% of Strategic Investment Advisors's portfolio in Q1 2026, its #186 holding.
  • Strategic Investment Advisors first reported a position in Gilead Sciences in Q3 2019 and has held it in 23 quarters since.
  • Strategic Investment Advisors's Gilead Sciences position peaked at $4.83M in Q3 2024.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Strategic Investment Advisors's 13F filing for Q1 2026, filed 18 May 2026.